Abstract

Drug combinations may exhibit synergistic or antagonistic effects. Rational design of synergistic drug combinations remains a challenge despite active experimental and computational efforts. Because drugs manifest their action via their targets, the effects of drug combinations should depend on the interaction of their targets in a network manner. We therefore modeled the effects of drug combinations along with their targets interacting in a network, trying to elucidate the relationships between the network topology involving drug targets and drug combination effects. We used three-node enzymatic networks with various topologies and parameters to study two-drug combinations. These networks can be simplifications of more complex networks involving drug targets, or closely connected target networks themselves. We found that the effects of most of the combinations were not sensitive to parameter variation, indicating that drug combinational effects largely depend on network topology. We then identified and analyzed consistent synergistic or antagonistic drug combination motifs. Synergistic motifs encompass a diverse range of patterns, including both serial and parallel combinations, while antagonistic combinations are relatively less common and homogenous, mostly composed of a positive feedback loop and a downstream link. Overall our study indicated that designing novel synergistic drug combinations based on network topology could be promising, and the motifs we identified could be a useful catalog for rational drug combination design in enzymatic systems.

Highlights

  • Drug combinations have been envisaged by many to be a promising approach to treat complex diseases such as cancer, inflammation and type 2 diabetes [1,2,3]

  • Drug synergy/antagonism is a property largely determined by network topology

  • We modeled patterns of possible drug combinations in all possible three-node enzymatic network topologies, using presampled 100,000 parameter sets (Work flow summarized in Figure 1, detailed in Methods)

Read more

Summary

Introduction

Drug combinations have been envisaged by many to be a promising approach to treat complex diseases such as cancer, inflammation and type 2 diabetes [1,2,3]. Based on topological relationships between drug targets, they devised a synergy score to rank and select possible synergistic drug pairs. By surveying the existing synergistic drug pairs and their topological relations in biological networks, Zou et al [12] suggested that synergistic drug target combinations tend to be in so called neighbor communities. Based on this concept they trained a support vector machine (SVM) classifier and successfully retrieved and experimentally confirmed several synergistic drug pairs. Noting the similarity between drug synergy and genetic interaction, Cokol et al [13] suggested that gene pairs manifesting negative genetic interactions may be possible synergistic drug target pairs. It is of great interest to predict drug synergy or antagonism based on the topology of the drug target network

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call